| Dr Eleni Marie Rettig, MD | |
|
200 1st St Sw, Rochester, MN 55905 | |
| (507) 284-2511 | |
| Not Available |
| Full Name | Dr Eleni Marie Rettig |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 13 Years |
| Location | 200 1st St Sw, Rochester, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972802197 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 63424 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Faulkner Hospital-brigham And Women's | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brigham And Women's Physicians Organization Inc | 3870405988 | 2510 |
| Dana-farber Cancer Institute, Inc. | 9133038904 | 538 |
News Archive
New recommendations for best practice for infection prevention and control in healthcare settings, to help stop the spread of COVID-19, have been developed by the University of Adelaide's JBI, an international research organisation in the Faculty of Health and Medical Sciences.
We're in denial: Americans underestimate their chances of needing long-term care as they get older -; and are taking few steps to get ready.
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.
A new analysis led by researchers at Johns Hopkins Bloomberg School of Public Health found that the number of U.S. prison residents who tested positive for COVID-19 was 5.5 times higher than the general U.S. population, with a prisoner case rate of 3,251 per 100,000 residents as compared to 587 cases per 100,000 in the general population.
› Verified 1 days ago
| Entity Name | Dana-farber Cancer Institute, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851333686 PECOS PAC ID: 9133038904 Enrollment ID: O20040223000228 |
News Archive
New recommendations for best practice for infection prevention and control in healthcare settings, to help stop the spread of COVID-19, have been developed by the University of Adelaide's JBI, an international research organisation in the Faculty of Health and Medical Sciences.
We're in denial: Americans underestimate their chances of needing long-term care as they get older -; and are taking few steps to get ready.
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.
A new analysis led by researchers at Johns Hopkins Bloomberg School of Public Health found that the number of U.S. prison residents who tested positive for COVID-19 was 5.5 times higher than the general U.S. population, with a prisoner case rate of 3,251 per 100,000 residents as compared to 587 cases per 100,000 in the general population.
› Verified 1 days ago
| Entity Name | Brigham And Women's Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033535497 PECOS PAC ID: 3870405988 Enrollment ID: O20150107001260 |
News Archive
New recommendations for best practice for infection prevention and control in healthcare settings, to help stop the spread of COVID-19, have been developed by the University of Adelaide's JBI, an international research organisation in the Faculty of Health and Medical Sciences.
We're in denial: Americans underestimate their chances of needing long-term care as they get older -; and are taking few steps to get ready.
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.
A new analysis led by researchers at Johns Hopkins Bloomberg School of Public Health found that the number of U.S. prison residents who tested positive for COVID-19 was 5.5 times higher than the general U.S. population, with a prisoner case rate of 3,251 per 100,000 residents as compared to 587 cases per 100,000 in the general population.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eleni Marie Rettig, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Dr Eleni Marie Rettig, MD 200 1st St Sw, Rochester, MN 55905 Ph: (507) 284-2511 |
News Archive
New recommendations for best practice for infection prevention and control in healthcare settings, to help stop the spread of COVID-19, have been developed by the University of Adelaide's JBI, an international research organisation in the Faculty of Health and Medical Sciences.
We're in denial: Americans underestimate their chances of needing long-term care as they get older -; and are taking few steps to get ready.
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.
A new analysis led by researchers at Johns Hopkins Bloomberg School of Public Health found that the number of U.S. prison residents who tested positive for COVID-19 was 5.5 times higher than the general U.S. population, with a prisoner case rate of 3,251 per 100,000 residents as compared to 587 cases per 100,000 in the general population.
› Verified 1 days ago
Dr. Kendall Krystyna Tasche, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Charles Wayne Beatty, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Jan L Kasperbauer, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Nicolas Ernest Maragos, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Laura J Orvidas, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Nicholas Reed Randall, MD Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Lazaro Rafael Peraza, MD Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |